Premier Value - NDC Database

17 records found

Page:1

61658-883 Jul 31, 2023
Premier Value 5.8 mg Oral Lozenge by Yunnan Baiyao Group Co., Ltd

61658-884 Jul 31, 2023
Premier Value 7.5 mg Oral Lozenge by Yunnan Baiyao Group Co., Ltd

61658-885 Jul 31, 2023
Premier Value 5.4 mg Oral Lozenge by Yunnan Baiyao Group Co., Ltd

61658-886 Jul 31, 2023
Premier Value 5.8 mg Oral Lozenge by Yunnan Baiyao Group Co., Ltd

68016-124 May 22, 2019
Premier Value 262 mg Oral Tablet, Chewable by Chain Drug Consortium, LLC

68016-220 Apr 16, 2019
Premier Value 625 mg Oral Tablet, Film Coated by Pharmacy Value Alliance, LLC

68016-744 Mar 20, 2019
Premier Value Oral Solution by Pharmacy Value Alliance LLC

68016-809 Jan 01, 2021
Premier Value 70 ml/100ml Topical Swab by Pharmacy Value Alliance, LLC

68016-831 May 19, 2009
Premier Value 999 mg/ml Oral Oil by Pharmacy Value Alliance LLC

68016-883 Jul 31, 2023
Premier Value 5.8 mg Oral Lozenge by Pharmacy Value Alliance LLC

68016-884 Jul 31, 2023
Premier Value 7.5 mg Oral Lozenge by Pharmacy Value Alliance LLC

68016-885 Jul 31, 2023
Premier Value 5.4 mg Oral Lozenge by Pharmacy Value Alliance LLC

68016-886 Jul 31, 2023
Premier Value 5.8 mg Oral Lozenge by Pharmacy Value Alliance LLC

83698-883 Jul 31, 2023
Premier Value 5.8 mg Oral Lozenge by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

83698-884 Jul 31, 2023
Premier Value 7.5 mg Oral Lozenge by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

83698-885 Jul 31, 2023
Premier Value 5.4 mg Oral Lozenge by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

83698-886 Jul 31, 2023
Premier Value 5.8 mg Oral Lozenge by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.